OncoResponse's Spinoff / Spinout Round

OncoResponse raised a round of funding on October 06, 2015. Investors include Theraclone Sciences.

OncoResponse mines the human adaptive immune system to discover therapeutic antibodies against immuno-oncology targets. By identifying candidates from the immune systems of patients who have responded…

Articles about OncoResponse's Spinoff / Spinout Round: